Novo Nordisk Joins as the First Diamond Sponsor of the International Congress on Neurodegenerative Diseases
)
)
)
The International Congress on Neurodegenerative Diseases will feature Novo Nordisk as its first Diamond Sponsor, the highest level of support established by the organization. This collaboration highlights the company’s commitment to science, research, and progress in addressing neurodegenerative diseases.
Thanks to this support, Novo Nordisk will be associated with the main driving forces behind the Congress—the Reina Sofía Foundation, the Center for Research on Neurological Diseases (CIEN), and the Ministry of Science, Innovation and Universities—positioning the company prominently within the institutional framework of the event.
With nearly a century of experience in medical innovation, Novo Nordisk works to improve the lives of people living with serious chronic diseases. Its participation in the Congress reflects a shared vision: science as a transformative tool capable of generating real and lasting impact.
This partnership represents a valuable boost for the Congress, which this year will bring together national and international leaders in the study of neurodegenerative diseases in Elche. Novo Nordisk’s commitment makes a decisive contribution to strengthening a space where knowledge and collaboration are placed at the service of those who need it most.
On behalf of the organization, we would like to thank Novo Nordisk for their trust and support. Their involvement will undoubtedly be key to the success of this edition.